openFDA Drug Label API -- A Developer's Complete Guide

The openFDA drug label API is a free, public REST API maintained by the U.S. Food and Drug Administration. It exposes drug labeling data derived from Structured Product Labeling (SPL) documents submitted by pharmaceutical manufacturers as part of the FDA approval and post-market labeling process. SPL is an HL7-defined XML document standard that the FDA adopted as the required format for all prescription and over-the-counter drug labeling submissions.

The API provides searchable access to the text content of FDA-approved drug labels, broken into named sections that correspond to the standard labeling format. For developers building drug interaction features, the most relevant sections are drug_interactions (Section 7 of the Physician Labeling Rule), warnings, contraindications, and boxed_warning. Each of these sections may contain information about how a drug interacts with other medications.

The openFDA drug label API is one of several openFDA endpoints. Others cover adverse events, drug recalls, and medical devices. This guide focuses specifically on the /drug/label.json endpoint, which is the foundation for any interaction detection system built on public FDA data. The API is free to use, requires no licensing agreement, and has clearly documented rate limits. It serves as the evidence layer for RxLabelGuard's interaction detection pipeline and is a building block that any developer can use directly.

Understanding this API thoroughly is valuable whether you plan to build your own interaction pipeline or simply want to understand how managed APIs like RxLabelGuard source their data. The sections below cover everything from getting an API key to advanced query patterns, caching strategies, and the limitations that lead most production teams to use a managed service rather than consuming openFDA directly.

The openFDA API works without authentication, but unauthenticated requests are limited to 40 requests per minute. Registering for a free API key at open.fda.gov increases that limit to 240 requests per minute and 120,000 requests per day. The key is appended to requests as a query parameter: api_key=YOUR_KEY.

Registration is straightforward: provide an email address, agree to the terms of service, and receive your key. There is no approval process, no organization requirement, and no cost. The key is issued immediately.

A few important details about rate limits. The 240 requests per minute limit is a hard ceiling; exceeding it returns HTTP 429 (Too Many Requests). The 120,000 per day limit resets at midnight UTC. Both limits apply per API key. If you need higher throughput, you can register multiple keys, though the openFDA terms of service expect this to be done in good faith rather than as a circumvention strategy.

For development and testing, the 240 per minute limit is more than sufficient. For production workloads that need to warm a cache across thousands of drugs, the rate limit requires careful request pacing. A queue-based approach with configurable concurrency is the standard pattern. The rate limiting and caching section later in this guide covers strategies in detail.

Each record in the openFDA drug label API represents a single FDA-approved drug label (an SPL document). A label corresponds to a specific product and version. The same drug may have multiple labels if it is manufactured by multiple companies (as is common for generic drugs) or if the label has been revised over time.

The top-level response from a query contains a meta object (with pagination information and a disclaimer) and a results array of label objects. Each label object contains dozens of fields corresponding to the standard labeling sections defined by the FDA's Physician Labeling Rule. The FDA prescribing labeling guidance defines the required sections and their content for prescription drug products.

The most important fields for drug interaction work are the following. The drug_interactions field contains the full text of Section 7 (Drug Interactions). This is the primary source for interaction statements. The warnings field contains general warnings that may include interaction-related safety information. The contraindications field lists absolute contraindications, which may include specific drug combinations. The boxed_warning field contains the most serious safety warnings, which may reference life-threatening drug interactions.

Every label object also contains an openfda sub-object that provides cross-reference identifiers. The spl_set_id is a stable UUID assigned to a product's labeling that persists across label revisions. This is the recommended identifier for caching and traceability. The rxcui field is an array of RxNorm Concept Unique Identifiers associated with the product. The product_ndc field contains National Drug Code identifiers. The generic_name and brand_name fields provide the drug's names in both forms. The effective_time field indicates when the label was last revised, expressed as a YYYYMMDD string.

The openFDA API uses a custom query syntax that is consistent across all its endpoints. Queries are constructed using URL parameters on the base URL https://api.fda.gov/drug/label.json. The primary parameter is search, which accepts field:value pairs with several operators.

A basic search looks like: search=openfda.generic_name:metformin. This returns all labels where the generic name matches metformin. Field names follow the JSON structure of the response object, so openfda.rxcui refers to the rxcui field within the openfda sub-object.

Multiple conditions can be combined with +AND+ and +OR+ operators. For example: search=openfda.generic_name:metformin+AND+openfda.brand_name:Glucophage. The plus signs are URL-encoded spaces, so these operators are literally AND and OR surrounded by spaces. Wildcard matching is supported with the asterisk character: search=openfda.generic_name:metform* would match metformin and any other generic name starting with metform.

Pagination is controlled with limit and skip parameters. The limit parameter controls how many results are returned per request, with a maximum of 1000. The skip parameter controls the offset into the result set, with a maximum of 25000. For most interaction work, you want the single most recent label for a drug, so limit=1 combined with sorting is the standard pattern.

Sorting is controlled with the sort parameter: sort=effective_time:desc returns results with the most recently updated label first. This is important because a drug may have many labels in the system (from different manufacturers and revision dates), and you typically want the most current one. The combination of search, sort, and limit gives you precise control over which label you retrieve.

Here are concrete examples of queries you will use when building an interaction detection pipeline. These are formatted as full URLs that you can test directly in a browser or with cURL.

Find a drug by generic name and get the most recent label:

https://api.fda.gov/drug/label.json?search=openfda.generic_name:metformin&sort=effective_time:desc&limit=1&api_key=YOUR_KEY

Find a drug by RxCUI (the most reliable query path after name resolution via RxNorm):

https://api.fda.gov/drug/label.json?search=openfda.rxcui:6809&sort=effective_time:desc&limit=1&api_key=YOUR_KEY

Find a drug by NDC code:

https://api.fda.gov/drug/label.json?search=openfda.product_ndc:"0378-0209"&sort=effective_time:desc&limit=1&api_key=YOUR_KEY

Extract the drug interactions text from a response. In the JSON response, the drug_interactions field is located at results[0].drug_interactions and contains an array of strings (typically a single string with the full Section 7 text). Some labels do not have this field at all, which means the label does not contain a dedicated drug interactions section. In those cases, interaction information may still exist in the warnings or contraindications fields.

Search for labels that contain the word warfarin in the drug_interactions field:

https://api.fda.gov/drug/label.json?search=drug_interactions:warfarin&sort=effective_time:desc&limit=5&api_key=YOUR_KEY

This last example is useful for discovering which drugs mention warfarin as an interaction target. However, free-text search on the drug_interactions field is imprecise: it will match any mention of the word, including informational statements that are not actual interaction warnings. For reliable interaction detection, the better approach is to retrieve labels by drug identifier and then parse the text programmatically.

While the openFDA label response contains dozens of fields, only a handful are essential for drug interaction detection. Understanding each one helps you build an efficient extraction pipeline.

The drug_interactions field (array of strings) contains the Section 7 text. This is your primary extraction target. The text is manufacturer-authored prose that describes known interactions with specific drugs, drug classes, and sometimes food or laboratory tests. The quality and structure of this text varies significantly between labels. Some are well-organized with clear subsections per interacting drug. Others are dense paragraphs covering multiple interactions. Some labels have no drug_interactions field at all.

The contraindications field (array of strings) often contains the most severe interaction information. When two drugs must absolutely not be used together, the contraindication is frequently stated here rather than (or in addition to) the drug_interactions section. Ignoring this field means missing some of the highest-severity interactions.

The warnings field (array of strings, sometimes called warnings_and_precautions in newer labels) describes safety concerns that include interaction-related risks. A warning about increased bleeding risk when used with anticoagulants is interaction-relevant even if it also appears in the drug_interactions section. Parsing this field catches interactions that are described in a safety context rather than a pure interaction context.

The boxed_warning field (array of strings) contains the most serious FDA warnings, colloquially known as black box warnings. When a drug interaction is severe enough to warrant a boxed warning, it represents the highest level of clinical concern. These are relatively rare but critically important to capture.

The openfda.spl_set_id field is your cache key and traceability identifier. It is stable across label revisions, meaning you can track when a label is updated without losing the relationship to previously cached data. The effective_time field tells you when the label was last revised, which you need for cache freshness checks. Together, spl_set_id and effective_time form the version-aware cache key for any label caching strategy.

The openFDA API's rate limits of 240 requests per minute and 120,000 per day are generous for on-demand queries but constrain bulk operations. If you need to retrieve labels for a large drug catalog (thousands of drugs), you need a caching layer and a controlled warm-up process.

The recommended caching strategy keys entries on spl_set_id, which is the stable identifier for a product's labeling across versions. When you retrieve a label from openFDA, store the full response (or at minimum the interaction-relevant fields) along with the effective_time and a cache timestamp. On subsequent requests for the same drug, check the cache first. If the cache entry exists and is within your TTL window, use it directly without calling openFDA.

What TTL should you use? FDA labels do not change frequently. Most labels are updated quarterly or less often. A 7-day TTL is conservative and safe for virtually all use cases. A 24-hour TTL is appropriate for systems that need tighter freshness guarantees. Going below 24 hours provides minimal benefit because openFDA's own indexing of new label versions can lag by days.

For cache warming, pace your requests to stay comfortably below the 240 per minute limit. A practical target is 200 requests per minute with a small buffer. At that rate, you can warm a cache of 1,000 drugs in about 5 minutes. For larger catalogs, a background job that processes a queue of drugs with configurable concurrency and rate limiting is the standard approach.

Cache invalidation can be handled by a periodic freshness check job. On a daily or weekly schedule, query openFDA for each cached drug (sorted by effective_time descending) and compare the effective_time against your cached version. If the API returns a newer effective_time, invalidate the cache entry. This approach is far more efficient than re-fetching all labels on a schedule, because you only re-fetch labels that have actually been updated.

The openFDA drug label API is a powerful data source, but it has fundamental limitations that affect its suitability as a production interaction detection system. Understanding these limitations is important for setting expectations and planning your architecture.

The most significant limitation is that the data is unstructured text. The drug_interactions field contains prose, not data. It describes interactions in natural language written for healthcare professionals. There are no structured fields for interacting drug names, severity levels, mechanisms of action, or clinical recommendations. Every piece of structured interaction data you need must be extracted from this text through natural language processing.

There is no severity scoring. FDA labels use phrases like 'concomitant use is contraindicated' or 'may require dose adjustment,' but they do not assign standardized severity levels. Building a severity classification system requires mapping label language patterns to a severity scale, which involves both deterministic rules and judgment calls for ambiguous cases.

There are no structured interaction pairs. A label for Drug A may describe interactions with Drug B, Drug C, and an entire drug class (such as NSAIDs or CYP3A4 inhibitors), all within the same paragraph. Extracting discrete pairs from this text, and resolving drug class mentions to specific drugs, is a non-trivial NLP problem.

Not all labels have a drug_interactions field. Some drugs, particularly older generics and OTC products, have labels that lack this section entirely. Interaction information for these drugs may exist only in the warnings or contraindications sections, or may not be documented in the label at all.

Multiple labels exist for the same drug. A generic drug manufactured by ten different companies will have ten labels in openFDA. These labels may contain slightly different wording for the same interactions, or different levels of detail. Your pipeline needs a strategy for choosing which label to use (typically the most recently updated one) and optionally reconciling information across multiple labels for the same drug.

The gap between raw openFDA label text and structured interaction data is the engineering problem that defines drug interaction API development. This section outlines the architecture for bridging that gap. It is the same architecture that RxLabelGuard implements as a managed service.

The pipeline has five stages. Stage 1 is drug input resolution: converting user-provided drug names (which may be brand names, generics, abbreviations, or misspellings) into canonical identifiers. This is handled by querying the RxNorm API, which remains free and publicly available. The key endpoint is /rxcui.json for exact matching, with /approximateTerm.json as a fuzzy fallback. The output of this stage is an RxCUI for each input drug. The RxNorm API documentation at the NLM RxNav site covers these endpoints in detail.

Stage 2 is label retrieval: using the resolved RxCUI to fetch the drug's label from openFDA. The query pattern is search=openfda.rxcui:{rxcui}&sort=effective_time:desc&limit=1. If the RxCUI query returns no results (which happens for some older or less common drugs), fallback strategies include querying by NDC, generic name, or brand name. The result is the raw label text, from which the drug_interactions, warnings, contraindications, and boxed_warning fields are extracted.

Stage 3 is interaction extraction: parsing the label prose into structured interaction records. This typically uses a two-pass approach. A deterministic first pass handles sentence splitting, keyword detection (phrases like 'contraindicated with,' 'should not be used concomitantly,' 'may increase the risk of'), and named entity recognition to identify drug names and drug classes in the text. A second pass using a large language model (such as Claude via AWS Bedrock) handles the nuanced cases where interactions are described indirectly or require contextual interpretation. The LLM produces structured JSON with target drug, mechanism, recommendation, and evidence snippet.

Stage 4 is severity classification: assigning a severity level (contraindicated, major, moderate, minor, or unknown) to each extracted interaction based on the language in the label. Explicit contraindication language maps to the highest level. Boxed warning mentions map to major or contraindicated. Dose adjustment language typically maps to moderate. The severity levels documentation at /docs/severity-levels describes the classification criteria used by RxLabelGuard.

Stage 5 is response formatting: assembling the extracted, classified interactions into a stable API response with evidence citations linking each interaction back to its source label section and spl_set_id. This stage also handles cross-matching between drug pairs (checking Drug A's label for mentions of Drug B and vice versa) and deduplication of interactions found in multiple label sections.

Developers working with the openFDA API for the first time encounter several common issues. Being aware of these upfront saves debugging time.

Rate limit exceeded errors (HTTP 429) are the most frequent issue during development. If you are testing iteratively and making many requests in quick succession, you will hit the 240 per minute limit. The response includes a Retry-After header. Implement backoff logic from the start, even during development. A simple sleep between requests is sufficient for testing; a proper queue-based rate limiter is needed for production.

Missing drug_interactions field catches many developers off guard. Not all labels contain a drug_interactions section. When querying by generic name, you may get a label that lacks this field entirely. Your code must handle this case gracefully. Check for the field's existence before attempting to access it, and consider falling back to the warnings and contraindications fields as alternative evidence sources.

Multiple labels per drug is a source of confusion. Searching for a common generic drug may return dozens of labels from different manufacturers. Without the sort=effective_time:desc&limit=1 parameters, you may process an outdated label or waste time deduplicating across manufacturers. Always sort by effective_time descending and take the first result unless you have a specific reason to process multiple labels.

Effective_time sorting importance cannot be overstated. FDA labels are revised when safety information changes, which often includes new drug interactions discovered through post-market surveillance. Using an older label version means potentially missing interactions that were added in later revisions. The effective_time field is your versioning mechanism. Always use it for both query sorting and cache freshness checks.

URL encoding of search queries trips up many developers. The +AND+ and +OR+ operators must be properly URL-encoded. Special characters in drug names (hyphens, slashes in NDC codes) may need encoding. Testing queries in a browser first helps identify encoding issues before they become bugs in your application code.

The count parameter can produce unexpected results. openFDA supports a count parameter for aggregation queries, but it operates differently from the search parameter. Using count on label fields returns frequency distributions, not filtered results. Stick to the search/sort/limit pattern for label retrieval.

The openFDA drug label API is a powerful, free data source. Whether you should use it directly or consume it through a managed API depends on your goals, timeline, and engineering capacity.

Use openFDA directly when your goal is learning or research. If you want to understand how FDA labels are structured, explore interaction language patterns across different drug classes, or build a proof of concept for a clinical tool, working directly with openFDA is the best way to develop domain expertise. The API is well-documented, free, and provides access to the same underlying data that every drug information product ultimately derives from.

Use openFDA directly when you have specific requirements that demand full pipeline control. If your extraction logic needs to be tuned to a specific clinical domain (oncology interactions, for example), if your regulatory environment requires that all data processing happens within your own infrastructure, or if you need to combine openFDA data with proprietary clinical data sources, building your own pipeline gives you that control.

Use a managed API when you need structured interaction data as a building block. If drug interaction checking is one feature in a larger product, and you need severity-scored, evidence-cited interaction pairs in a stable JSON format, building and maintaining the full extraction pipeline is a distraction from your core product. The engineering time spent on label parsing, severity classification, cross-matching, and cache management is engineering time not spent on your product's differentiating features.

Use a managed API when time-to-market matters. A managed service like RxLabelGuard lets you go from zero to working interaction checks in minutes rather than months. The free tier at /register lets you validate the API against your requirements before committing any budget. The full API documentation at /docs covers every aspect of the integration.

Many teams use both: openFDA directly for research and validation, and a managed API for production. This hybrid approach gives you transparency into the underlying data while avoiding the operational burden of maintaining an extraction pipeline. Our comparison page at /compare discusses this and other integration patterns in detail.

This guide has covered the openFDA drug label API from end to end: its data model, query syntax, rate limits, key fields for interaction work, caching strategies, limitations, and the architecture for turning raw label text into structured interaction data.

If you want to go deeper into the extraction architecture, our post on building an interaction API with RxNorm and SPL at /blog/building-an-interaction-api-with-rxnorm-and-spl covers the pipeline stages in more detail, with pseudocode examples and testing strategies.

If you are evaluating openFDA alongside DailyMed as a data source, our comparison of the two at /blog/openfda-vs-dailymed-for-interaction-workflows covers the trade-offs in query flexibility, data freshness, bulk download capabilities, and production architecture patterns.

If you want structured interaction data without building the pipeline yourself, create a free account at /register and start making API calls in minutes. The RxLabelGuard API handles drug name resolution, label retrieval, interaction extraction, severity classification, and evidence citation as a managed service. The pricing page at /pricing covers all three tiers, starting at $0 per month for the Sandbox.

For a broader view of how RxLabelGuard compares to other drug interaction data sources including DrugBank, First Databank, and Micromedex, the drug interaction API page at /drug-interaction-api and the free tier page at /free-drug-interaction-api provide additional context and comparison tables.